Connacht Asset Management LP - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
Connacht Asset Management LP ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q2 2023$236,104
-2.4%
7,238
+5.3%
0.32%
+213.6%
Q1 2023$241,896
-18.8%
6,874
+5.8%
0.10%
-23.7%
Q4 2022$297,830
-51.6%
6,500
-48.8%
0.14%
-69.1%
Q3 2022$615,000
+178.3%
12,704
+126.3%
0.44%
+369.9%
Q2 2022$221,000
-18.8%
5,615
-24.0%
0.09%
-33.1%
Q1 2022$272,000
-50.4%
7,390
-38.5%
0.14%
-74.0%
Q4 2021$548,00012,0170.54%
Other shareholders
CYTOKINETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders